Literature DB >> 31191855

The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry.

Thomas M Wood1,2, Nathaniel I Martin2.   

Abstract

To push back the growing tide of antibacterial resistance the discovery and development of new antibiotics is a must. In recent years the calcium-dependent lipopeptide antibiotics (CDAs) have emerged as a potential source of new antibacterial agents rich in structural and mechanistic diversity. All CDAs share a common lipidated cyclic peptide motif containing amino acid side chains that specifically chelate calcium. It is only in the calcium bound state that the CDAs achieve their potent antibacterial activities. Interestingly, despite their common structural features, the mechanisms by which different CDAs target bacteria can vary dramatically. This review provides both a historic context for the CDAs while also addressing the state of the art with regards to their discovery, optimization, and antibacterial mechanisms.

Entities:  

Year:  2019        PMID: 31191855      PMCID: PMC6533798          DOI: 10.1039/c9md00126c

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  59 in total

1.  Amphomycin inhibits phospho-N-acetylmuramyl-pentapeptide translocase in peptidoglycan synthesis of Bacillus.

Authors:  H Tanaka; R Oiwa; S Matsukura; S Omura
Journal:  Biochem Biophys Res Commun       Date:  1979-02-14       Impact factor: 3.575

2.  Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.

Authors:  James S Lewis; Aaron Owens; Jose Cadena; Kathryn Sabol; Jan E Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae.

Authors:  Vivian Miao; Renee Brost; Joanne Chapple; Kevin She; Marie-François Coëffet-Le Gal; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2005-10-06       Impact factor: 3.346

4.  Structure of the lipopeptide antibiotic tsushimycin.

Authors:  Gábor Bunkóczi; László Vértesy; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-07-20

5.  Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.

Authors:  Francisco M Marty; Wendy W Yeh; Christine B Wennersten; Lata Venkataraman; Esperanza Albano; Edwin P Alyea; Howard S Gold; Lindsey R Baden; Satish K Pillai
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. I. Taxonomic studies of the producing microorganism and fermentation.

Authors:  W Aretz; J Meiwes; G Seibert; G Vobis; J Wink
Journal:  J Antibiot (Tokyo)       Date:  2000-08       Impact factor: 2.649

Review 7.  Natural products to drugs: daptomycin and related lipopeptide antibiotics.

Authors:  Richard H Baltz; Vivian Miao; Stephen K Wrigley
Journal:  Nat Prod Rep       Date:  2005-11-04       Impact factor: 13.423

8.  Laspartomycin, an acidic lipopeptide antibiotic with a unique peptide core.

Authors:  Donald B Borders; Richard A Leese; Howard Jarolmen; Noreen D Francis; Amadeo A Fantini; Tim Falla; John C Fiddes; André Aumelas
Journal:  J Nat Prod       Date:  2007-02-22       Impact factor: 4.050

9.  Structure determination of glycinocins A to D, further evidence for the cyclic structure of the amphomycin antibiotics.

Authors:  Fangming Kong; Guy T Carter
Journal:  J Antibiot (Tokyo)       Date:  2003-06       Impact factor: 2.649

10.  Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor.

Authors:  Zohreh Hojati; Claire Milne; Barbara Harvey; Lyndsey Gordon; Matthew Borg; Fiona Flett; Barrie Wilkinson; Philip J Sidebottom; Brian A M Rudd; Martin A Hayes; Colin P Smith; Jason Micklefield
Journal:  Chem Biol       Date:  2002-11
View more
  6 in total

1.  Unconventional Antibacterials and Adjuvants.

Authors:  Mayland Chang; Kiran V Mahasenan; Juan A Hermoso; Shahriar Mobashery
Journal:  Acc Chem Res       Date:  2021-01-29       Impact factor: 22.384

2.  Comprehensive genome analysis of Lentzea reveals repertoire of polymer-degrading enzymes and bioactive compounds with clinical relevance.

Authors:  Pulak Kumar Maiti; Sukhendu Mandal
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

3.  Phosphate Ions Alter the Binding of Daptomycin to Living Bacterial Cell Surfaces.

Authors:  Lindsey N Miller; Marea J Blake; Eleanor F Page; Hannah B Castillo; Tessa R Calhoun
Journal:  ACS Infect Dis       Date:  2021-10-03       Impact factor: 5.578

Review 4.  Genome mining methods to discover bioactive natural products.

Authors:  Katherine D Bauman; Keelie S Butler; Bradley S Moore; Jonathan R Chekan
Journal:  Nat Prod Rep       Date:  2021-11-17       Impact factor: 13.423

5.  Mechanistic insights into the C55-P targeting lipopeptide antibiotics revealed by structure-activity studies and high-resolution crystal structures.

Authors:  Thomas M Wood; Matthieu R Zeronian; Ned Buijs; Kristine Bertheussen; Hanieh K Abedian; Aidan V Johnson; Nicholas M Pearce; Martin Lutz; Johan Kemmink; Tjalling Seirsma; Leendert W Hamoen; Bert J C Janssen; Nathaniel I Martin
Journal:  Chem Sci       Date:  2022-02-21       Impact factor: 9.825

Review 6.  Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort.

Authors:  Elizabeth V K Ledger; Akshay Sabnis; Andrew M Edwards
Journal:  Microbiology (Reading)       Date:  2022-02       Impact factor: 2.777

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.